281 related articles for article (PubMed ID: 32330322)
1. Did Whatsapp
Duong TA; Velter C; Rybojad M; Comte C; Bagot M; Sulimovic L; Bouaziz JD
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e348-e350. PubMed ID: 32330322
[No Abstract] [Full Text] [Related]
2. Cutaneous manifestation of COVID-19 in images: a case report.
Avellana Moreno R; Estela Villa LM; Avellana Moreno V; Estela Villa C; Moreno Aparicio MA; Avellana Fontanella JA
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e307-e309. PubMed ID: 32330339
[No Abstract] [Full Text] [Related]
3. Acral cutaneous lesions in the time of COVID-19.
Recalcati S; Barbagallo T; Frasin LA; Prestinari F; Cogliardi A; Provero MC; Dainese E; Vanzati A; Fantini F
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e346-e347. PubMed ID: 32330324
[No Abstract] [Full Text] [Related]
4. Cutaneous manifestations in COVID-19: a first perspective.
Recalcati S
J Eur Acad Dermatol Venereol; 2020 May; 34(5):e212-e213. PubMed ID: 32215952
[No Abstract] [Full Text] [Related]
5. Mass quarantine measures in the time of COVID-19 pandemic: psychosocial implications for chronic skin conditions and a call for qualitative studies.
Garcovich S; Bersani FS; Chiricozzi A; De Simone C
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e293-e294. PubMed ID: 32330329
[No Abstract] [Full Text] [Related]
6. Cutaneous manifestation of COVID-19 reporting from Middle-Eastern countries: A point of view!
Abdelmaksoud A; Shakshouk H; Goldust M; Dursun R; Temiz SA; Vestita M
Int J Dermatol; 2020 Dec; 59(12):1547-1548. PubMed ID: 33099771
[No Abstract] [Full Text] [Related]
7. Symmetric cutaneous vasculitis in COVID-19 pneumonia.
Castelnovo L; Capelli F; Tamburello A; Faggioli PM; Mazzone A
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e362-e363. PubMed ID: 32378747
[No Abstract] [Full Text] [Related]
8. Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome.
Tammaro A; Adebanjo GAR; Parisella FR; Pezzuto A; Rello J
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e306-e307. PubMed ID: 32330340
[No Abstract] [Full Text] [Related]
9. European Task Force on Contact Dermatitis statement on coronavirus disease-19 (COVID-19) outbreak and the risk of adverse cutaneous reactions.
Balato A; Ayala F; Bruze M; Crepy MN; Gonçalo M; Johansen J; John SM; Pigatto P; Raimondo A; Rustemeyer T; Schuttelaar MA; Svedman C; Aerts O; Uter W; Wilkinson M; Gimenez-Arnau A
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e353-e354. PubMed ID: 32356382
[No Abstract] [Full Text] [Related]
10. Polymorphic cutaneous manifestations of COVID-19 infection in a single viral host.
Patel N; Kho J; Smith KE; Ahmed A; Van den Abbeele K; Mandal AKJ; Missouris CG
Int J Dermatol; 2020 Sep; 59(9):1149-1150. PubMed ID: 32686096
[No Abstract] [Full Text] [Related]
11. Dermatology staff participate in fight against Covid-19 in China.
Zheng Y; Lai W
J Eur Acad Dermatol Venereol; 2020 May; 34(5):e210-e211. PubMed ID: 32201983
[No Abstract] [Full Text] [Related]
12. COVID-19 and dermatology: a comprehensive guide for dermatologists.
Fahmy DH; El-Amawy HS; El-Samongy MA; Fouda AA; Soliman SH; El-Kady A; Farnetani F; Conti A; Zoeir A; Eissa A; Eissa R; Puliatti S; Sighinolfi MC; Rocco B; Pellacani G
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1388-1394. PubMed ID: 32428303
[No Abstract] [Full Text] [Related]
13. Pitfalls of possible reporting of same patients with COVID-19 in dermatology journals.
Kluger N
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e309-e310. PubMed ID: 32490552
[No Abstract] [Full Text] [Related]
14. Occupational skin conditions on the front line: a survey among 484 Chinese healthcare professionals caring for Covid-19 patients.
Pei S; Xue Y; Zhao S; Alexander N; Mohamad G; Chen X; Yin M
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e354-e357. PubMed ID: 32362062
[No Abstract] [Full Text] [Related]
15. Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms.
Altayeb A; Cordaro A; Caesar J; Vyas J; Ingram J
Int J Dermatol; 2020 Dec; 59(12):1541-1542. PubMed ID: 33084036
[No Abstract] [Full Text] [Related]
16. Oral vesicles and acral erythema: report of a cutaneous manifestation of COVID-19.
Aghazadeh N; Homayouni M; Sartori-Valinotti JC
Int J Dermatol; 2020 Sep; 59(9):1153-1154. PubMed ID: 32710552
[No Abstract] [Full Text] [Related]
17. Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.
Quaglino P; Fava P; Brizio M; Marra E; Rubatto M; Agostini A; Tonella L; Ribero S; Fierro MT
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1395-1396. PubMed ID: 32426877
[No Abstract] [Full Text] [Related]
18. Cutaneous manifestations of COVID-19: A preliminary review.
Jia JL; Kamceva M; Rao SA; Linos E
J Am Acad Dermatol; 2020 Aug; 83(2):687-690. PubMed ID: 32422225
[No Abstract] [Full Text] [Related]
19. Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.
Piccolo V; Neri I; Filippeschi C; Oranges T; Argenziano G; Battarra VC; Berti S; Manunza F; Fortina AB; Di Lernia V; Boccaletti V; De Bernardis G; Brunetti B; Mazzatenta C; Bassi A
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e291-e293. PubMed ID: 32330334
[No Abstract] [Full Text] [Related]
20. Dermatologic surgery training during the COVID-19 era.
García-Lozano JA; Cuellar-Barboza A; Garza-Rodríguez V; Vázquez-Martínez O; Ocampo-Candiani J
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e370-e372. PubMed ID: 32386437
[No Abstract] [Full Text] [Related]
[Next] [New Search]
